Report Highlights
The global blood transfusion and intravenous equipment market is estimated to increase from $19.0 billion in 2021 to reach $25.3 billion by 2026, at a compound annual growth rate (CAGR) of 5.9% during the forecast period of 2021-2026.
Report Includes
- 65 data tables and 33 additional tables
- An up-to-date review of the global blood transfusion and intravenous (IV) equipment market
- Analyses of the global market trends, with historic revenue (sales) data from 2019-2021, and projections of compound annual growth rates (CAGRs) through 2026
- Highlights of the upcoming market potential for blood transfusion and intravenous equipment, and areas of focus to forecast this market into various segments and sub-segments
- Evaluation and forecast the global market size for blood transfusion and IV equipment revenues, projected growth trends, and corresponding market share analysis by product type, end user, and geographic region
- Technology assessment of the key drivers, restraints and opportunities that will shape the market over the next five years (2021 to 2027)
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- In-depth information on R&D investment, key technology issues, industry specific challenges, major types of end-user markets, and COVID-19 implications on the progress of this market
- Descriptive company profiles of the leading global players, including B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Co., Cardinal Health, ICU Medical Inc., and Medline Industries
Report Scope
The scope of this report is broad. It covers blood transfusion products, blood intravenous products and end users of blood transfusion and intravenous equipment. The market has been segmented by transfusion products into apheresis devices, blood bags and accessories, blood component separators, blood mixers, consumables and supplies, filters, fridges and freezers, and pathogen reduction systems. Revenue forecasts for 2021-2026 are given for each segment and regional market with estimated values derived from the revenue of manufacturers’ total revenues. The main geographic markets, including North America, Europe, Asia-Pacific and the Rest of the World (ROW), are included.
The report also includes a discussion of the major players across each region in the blood transfusion and intravenous equipment market. Further, it explains the major drivers and regional dynamics of the global blood transfusion and intravenous equipment market and current trends within the industry.
Key industry acquisitions and strategic alliances are given from 2015 to 2020.
This report also examines the main patent trends within the industry and profiles market players that deal in blood transfusion and intravenous equipment.
The report concludes with a special focus on the vendor landscape and includes detailed profiles of the main vendors in the global blood transfusion and intravenous equipment market.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2020 | ||||||||||||||||||||||
| Forecast period considered | 2021-2026 | ||||||||||||||||||||||
| Base year market size | $6.0 billion | ||||||||||||||||||||||
| Market size forecast | $8.1 billion | ||||||||||||||||||||||
| Growth rate | CAGR of 5.0% from 2021 to 2026 | ||||||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||||||
| Segments covered | Product, End User | ||||||||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, Rest of the World (RoW) | ||||||||||||||||||||||
| Countries covered | U.S., Canada, Germany, U.K., France, Italy, Spain, Rest of Europe, Japan, China, India, South Korea, Rest of Asia-Pacific | ||||||||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||||||||
| Companies studied |
|
||||||||||||||||||||||
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Global Electric Vehicle Battery Reuse and Recycling Market (FCB058B)
- Artificial Intelligence (AI) in Cancer (BIO196B)
- Nutraceuticals: Global Markets (FOD013J)
- Protective Relays and Circuit Breakers: Global Markets (IAS157B)
- Global Market Opportunities and Competitive Landscape for CDMO (PHM238B)
Report Highlights
The global blood transfusion market should grow from $5.9 billion in 2018 to $7.6 billion by 2023 with a compound annual growth rate (CAGR) of 5.1% for the period of 2018-2023.
Report Includes
- 75 data tables and 27 additional tables
- Industry analysis of the global blood transfusion and intravenous (IV) equipment market
- Analyses of the global market trends with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024
- Information on major drivers and regional dynamics of the market and current trends within the industry
- Discussion of the major players across each regional market; their market shares, growth strategies and product portfolios
- Patent evaluation, including coverage of the current state of technology, new patent applications, and newly issued patents
- Emphasis on the vendor landscape and detailed profiles of the major vendors in the global blood transfusion and intravenous (IV) equipment market, including Abbott, Becton Dickinson, Baxter International Inc., Medline Industries, Poly Medicure Ltd., and Smiths Medical
Related Reports
Infusion Pumps and Devices: Technologies and Global Markets
The global market for infusion pumps is expected to grow from $10.1 billion in 2024 and is projected to reach $14.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% during the forecast period of 2024 to 2029.
Artificial Blood: Global Markets to 2028
The global artificial blood market reached $23.9 million in 2022, should reach $26.1 million by 2023 and $40.5 million by 2028 with a compound annual growth rate (CAGR) of 9.2% during the forecast period of 2023-2028.
Thawing Systems: Global Markets
The global market for thawing systems is estimated to increase from $242.2 million in 2022 to reach $341.4 million by 2027, at a compound annual growth rate (CAGR) of 7.1% from 2022 through 2027.
Global Markets for Blood Plasma Products
The global blood plasma products market should reach $45.7 billion by 2027 from $33.2 billion in 2022 at a compound annual growth rate (CAGR) of 6.6% for the forecast period of 2022 to 2027.
Recent Reports
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Top Trending Reports
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More